_id
69104f88ccc777a4e85d53a3
Ticker
CLDI
Name
Calidi Biotherapeutics Inc.
Exchange
NYSE MKT
Address
4475 Executive Drive, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.calidibio.com
Description
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Last Close
1.14
Volume
130154
Current Price
1.17
Change
0.02
Last Updated
2026-01-02T11:29:11.515Z
Image
data:image/webp;base64,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
Ipo Date
2021-11-01T00:00:00.000Z
Market Cap
8386233
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
120.0048
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
427000
Gross Profit
-427000
Operating Expenses
4621000
Operating Income
-5048000
Interest Expense
41000
Pretax Income
-5171000
Net Income
-5149000
Eps
-1.0493173018137354
Dividends Per Share
5673000
Shares Outstanding
7167721
Income Tax Expense
10000
EBITDA
-4703000
Operating Margin
-
Total Other Income Expense Net
-123000
Cash
10375000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
11028000
Property Plant Equipment
2012000
Total Assets
14029000
Payables
1143000
Short Term Debt
2276000
Long Term Debt
600000
Total Liabilities
6831000
Equity
6918000
Bs_currency_symbol
USD
Depreciation
427000
Change In Working Capital
-113000
Cash From Operations
-4238000
Capital Expenditures
27000
Cash From Investing
-27000
Cash From Financing
9480000
Net Change In Cash
5096000
Cf_currency_symbol
USD
PE
3.25
PB
0.8298915871639201
ROE
-74.42902572997976
ROA
-36.702544728776104
FCF
-4265000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
427000
Quarters > 0 > income Statement > gross Profit
-427000
Quarters > 0 > income Statement > operating Expenses
4621000
Quarters > 0 > income Statement > operating Income
-5048000
Quarters > 0 > income Statement > interest Expense
41000
Quarters > 0 > income Statement > pretax Income
-5171000
Quarters > 0 > income Statement > net Income
-5149000
Quarters > 0 > income Statement > eps
-1.0493173018137354
Quarters > 0 > income Statement > dividends Per Share
5673000
Quarters > 0 > income Statement > shares Outstanding
4907000
Quarters > 0 > income Statement > income Tax Expense
10000
Quarters > 0 > income Statement > EBITDA
-4703000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-123000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10375000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11028000
Quarters > 0 > balance Sheet > property Plant Equipment
2012000
Quarters > 0 > balance Sheet > total Assets
14029000
Quarters > 0 > balance Sheet > payables
1143000
Quarters > 0 > balance Sheet > short Term Debt
2276000
Quarters > 0 > balance Sheet > long Term Debt
600000
Quarters > 0 > balance Sheet > total Liabilities
6831000
Quarters > 0 > balance Sheet > equity
6918000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5149000
Quarters > 0 > cash Flow > depreciation
427000
Quarters > 0 > cash Flow > change In Working Capital
-113000
Quarters > 0 > cash Flow > cash From Operations
-4238000
Quarters > 0 > cash Flow > capital Expenditures
27000
Quarters > 0 > cash Flow > cash From Investing
-27000
Quarters > 0 > cash Flow > cash From Financing
9480000
Quarters > 0 > cash Flow > net Change In Cash
5096000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.0493173018137354
Quarters > 0 > ratios > PB
0.8298915871639201
Quarters > 0 > ratios > ROE
-74.42902572997976
Quarters > 0 > ratios > ROA
-36.702544728776104
Quarters > 0 > ratios > FCF
-4265000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
407000
Quarters > 1 > income Statement > gross Profit
-407000
Quarters > 1 > income Statement > operating Expenses
5664000
Quarters > 1 > income Statement > operating Income
-5664000
Quarters > 1 > income Statement > interest Expense
52000
Quarters > 1 > income Statement > pretax Income
-5757000
Quarters > 1 > income Statement > net Income
-5715000
Quarters > 1 > income Statement > eps
-1.986444212721585
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
2877000
Quarters > 1 > income Statement > income Tax Expense
4000
Quarters > 1 > income Statement > EBITDA
-5298000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-93000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5279000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
50000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6049000
Quarters > 1 > balance Sheet > property Plant Equipment
2333000
Quarters > 1 > balance Sheet > total Assets
9351000
Quarters > 1 > balance Sheet > payables
1227000
Quarters > 1 > balance Sheet > short Term Debt
2192000
Quarters > 1 > balance Sheet > long Term Debt
600000
Quarters > 1 > balance Sheet > total Liabilities
7275000
Quarters > 1 > balance Sheet > equity
1764000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5761000
Quarters > 1 > cash Flow > depreciation
407000
Quarters > 1 > cash Flow > change In Working Capital
-67000
Quarters > 1 > cash Flow > cash From Operations
-4880000
Quarters > 1 > cash Flow > capital Expenditures
57000
Quarters > 1 > cash Flow > cash From Investing
-57000
Quarters > 1 > cash Flow > cash From Financing
-469000
Quarters > 1 > cash Flow > net Change In Cash
-5400000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.986444212721585
Quarters > 1 > ratios > PB
1.9082142857142854
Quarters > 1 > ratios > ROE
-323.9795918367347
Quarters > 1 > ratios > ROA
-61.116458132820014
Quarters > 1 > ratios > FCF
-4937000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
394000
Quarters > 2 > income Statement > gross Profit
-394000
Quarters > 2 > income Statement > operating Expenses
5062000
Quarters > 2 > income Statement > operating Income
-5062000
Quarters > 2 > income Statement > interest Expense
72000
Quarters > 2 > income Statement > pretax Income
-5059000
Quarters > 2 > income Statement > net Income
-4986000
Quarters > 2 > income Statement > eps
-2.2178353819916747
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
2248138
Quarters > 2 > income Statement > income Tax Expense
3000
Quarters > 2 > income Statement > EBITDA
-4593000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10561000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
50000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
11489000
Quarters > 2 > balance Sheet > property Plant Equipment
3431000
Quarters > 2 > balance Sheet > total Assets
15064000
Quarters > 2 > balance Sheet > payables
1198000
Quarters > 2 > balance Sheet > short Term Debt
2453000
Quarters > 2 > balance Sheet > long Term Debt
600000
Quarters > 2 > balance Sheet > total Liabilities
7765000
Quarters > 2 > balance Sheet > equity
6941000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5062000
Quarters > 2 > cash Flow > depreciation
394000
Quarters > 2 > cash Flow > change In Working Capital
-3035000
Quarters > 2 > cash Flow > cash From Operations
-7131000
Quarters > 2 > cash Flow > capital Expenditures
7000
Quarters > 2 > cash Flow > cash From Investing
-7000
Quarters > 2 > cash Flow > cash From Financing
8108000
Quarters > 2 > cash Flow > net Change In Cash
970000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.2178353819916747
Quarters > 2 > ratios > PB
0.37895425154876816
Quarters > 2 > ratios > ROE
-71.83402967872064
Quarters > 2 > ratios > ROA
-33.0987785448752
Quarters > 2 > ratios > FCF
-7138000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1504000
Quarters > 3 > income Statement > cost Of Revenue
393000
Quarters > 3 > income Statement > gross Profit
-393000
Quarters > 3 > income Statement > operating Expenses
3633000
Quarters > 3 > income Statement > operating Income
-4026000
Quarters > 3 > income Statement > interest Expense
175000
Quarters > 3 > income Statement > pretax Income
-4144999
Quarters > 3 > income Statement > net Income
-4097000
Quarters > 3 > income Statement > eps
-6.166326768661153
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
664415
Quarters > 3 > income Statement > income Tax Expense
3000
Quarters > 3 > income Statement > EBITDA
-3577000
Quarters > 3 > income Statement > operating Margin
-267.686170212766
Quarters > 3 > income Statement > total Other Income Expense Net
-118999
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
9591000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
10227000
Quarters > 3 > balance Sheet > property Plant Equipment
2934000
Quarters > 3 > balance Sheet > total Assets
14182000
Quarters > 3 > balance Sheet > payables
2072000
Quarters > 3 > balance Sheet > short Term Debt
4446000
Quarters > 3 > balance Sheet > long Term Debt
600000
Quarters > 3 > balance Sheet > total Liabilities
12214000
Quarters > 3 > balance Sheet > equity
1534000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4148000
Quarters > 3 > cash Flow > depreciation
393000
Quarters > 3 > cash Flow > change In Working Capital
-2250000
Quarters > 3 > cash Flow > cash From Operations
-5423000
Quarters > 3 > cash Flow > capital Expenditures
5000
Quarters > 3 > cash Flow > cash From Investing
-5000
Quarters > 3 > cash Flow > cash From Financing
13106000
Quarters > 3 > cash Flow > net Change In Cash
7694000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-6.166326768661153
Quarters > 3 > ratios > PB
0.5067572033898305
Quarters > 3 > ratios > ROE
-267.07953063885265
Quarters > 3 > ratios > ROA
-28.888732195741078
Quarters > 3 > ratios > FCF
-5428000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-3.609042553191489
Quarters > 3 > health Score
15
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1535000
Annuals > 0 > income Statement > gross Profit
-1535000
Annuals > 0 > income Statement > operating Expenses
21776000
Annuals > 0 > income Statement > operating Income
-21776000
Annuals > 0 > income Statement > interest Expense
933000
Annuals > 0 > income Statement > pretax Income
-22195000
Annuals > 0 > income Statement > net Income
-22143000
Annuals > 0 > income Statement > eps
-33.3270621524198
Annuals > 0 > income Statement > dividends Per Share
1671000
Annuals > 0 > income Statement > shares Outstanding
664415
Annuals > 0 > income Statement > income Tax Expense
14000
Annuals > 0 > income Statement > EBITDA
-19727000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-419000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9591000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10227000
Annuals > 0 > balance Sheet > property Plant Equipment
2934000
Annuals > 0 > balance Sheet > total Assets
14182000
Annuals > 0 > balance Sheet > payables
2072000
Annuals > 0 > balance Sheet > short Term Debt
4446000
Annuals > 0 > balance Sheet > long Term Debt
600000
Annuals > 0 > balance Sheet > total Liabilities
12214000
Annuals > 0 > balance Sheet > equity
1534000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-22209000
Annuals > 0 > cash Flow > depreciation
1535000
Annuals > 0 > cash Flow > change In Working Capital
-1698000
Annuals > 0 > cash Flow > cash From Operations
-19694000
Annuals > 0 > cash Flow > capital Expenditures
16000
Annuals > 0 > cash Flow > cash From Investing
-16000
Annuals > 0 > cash Flow > cash From Financing
27365000
Annuals > 0 > cash Flow > net Change In Cash
7642000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-33.3270621524198
Annuals > 0 > ratios > PB
0.5067572033898305
Annuals > 0 > ratios > ROE
-1443.4810951760105
Annuals > 0 > ratios > ROA
-156.1345367367085
Annuals > 0 > ratios > FCF
-19710000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1256000
Annuals > 1 > income Statement > gross Profit
-1256000
Annuals > 1 > income Statement > operating Expenses
27736000
Annuals > 1 > income Statement > operating Income
-28992000
Annuals > 1 > income Statement > interest Expense
3749000
Annuals > 1 > income Statement > pretax Income
-29200000
Annuals > 1 > income Statement > net Income
-29216000
Annuals > 1 > income Statement > eps
-208.44451420499138
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
140162
Annuals > 1 > income Statement > income Tax Expense
16000
Annuals > 1 > income Statement > EBITDA
-24195000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-208000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2049000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1360000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4303000
Annuals > 1 > balance Sheet > property Plant Equipment
5343000
Annuals > 1 > balance Sheet > total Assets
10019000
Annuals > 1 > balance Sheet > payables
2877000
Annuals > 1 > balance Sheet > short Term Debt
1923000
Annuals > 1 > balance Sheet > long Term Debt
2060000
Annuals > 1 > balance Sheet > total Liabilities
18254000
Annuals > 1 > balance Sheet > equity
-8235000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-29216000
Annuals > 1 > cash Flow > depreciation
1256000
Annuals > 1 > cash Flow > change In Working Capital
-6242000
Annuals > 1 > cash Flow > cash From Operations
-26983000
Annuals > 1 > cash Flow > capital Expenditures
585000
Annuals > 1 > cash Flow > cash From Investing
-478000
Annuals > 1 > cash Flow > cash From Financing
29044000
Annuals > 1 > cash Flow > net Change In Cash
1577000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-208.44451420499138
Annuals > 1 > ratios > PB
-0.01991372677595628
Annuals > 1 > ratios > ROE
354.77838494231935
Annuals > 1 > ratios > ROA
-291.6059486974748
Annuals > 1 > ratios > FCF
-27568000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
45000
Annuals > 2 > income Statement > cost Of Revenue
274000
Annuals > 2 > income Statement > gross Profit
-229000
Annuals > 2 > income Statement > operating Expenses
22899000
Annuals > 2 > income Statement > operating Income
-23128000
Annuals > 2 > income Statement > interest Expense
158000
Annuals > 2 > income Statement > pretax Income
-25416000
Annuals > 2 > income Statement > net Income
-25427000
Annuals > 2 > income Statement > eps
-360.2017254324206
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
70591
Annuals > 2 > income Statement > income Tax Expense
11000
Annuals > 2 > income Statement > EBITDA
-24998000
Annuals > 2 > income Statement > operating Margin
-51395.555555555555
Annuals > 2 > income Statement > total Other Income Expense Net
-2288000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
372000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
870
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
786000
Annuals > 2 > balance Sheet > property Plant Equipment
1086000
Annuals > 2 > balance Sheet > total Assets
2597000
Annuals > 2 > balance Sheet > payables
2124000
Annuals > 2 > balance Sheet > short Term Debt
5541000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
53037000
Annuals > 2 > balance Sheet > equity
-50440000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-25427000
Annuals > 2 > cash Flow > depreciation
260000
Annuals > 2 > cash Flow > change In Working Capital
3569000
Annuals > 2 > cash Flow > cash From Operations
-13214000
Annuals > 2 > cash Flow > capital Expenditures
428000
Annuals > 2 > cash Flow > cash From Investing
-494000
Annuals > 2 > cash Flow > cash From Financing
12087000
Annuals > 2 > cash Flow > net Change In Cash
-590653
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-360.2017254324206
Annuals > 2 > ratios > PB
-0.0016374201030927835
Annuals > 2 > ratios > ROE
50.41038858049167
Annuals > 2 > ratios > ROA
-979.0912591451676
Annuals > 2 > ratios > FCF
-13642000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-303.15555555555557
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
449000
Annuals > 3 > income Statement > cost Of Revenue
94000
Annuals > 3 > income Statement > gross Profit
355000
Annuals > 3 > income Statement > operating Expenses
10837000
Annuals > 3 > income Statement > operating Income
-10482000
Annuals > 3 > income Statement > interest Expense
614000
Annuals > 3 > income Statement > pretax Income
3397750
Annuals > 3 > income Statement > net Income
-10933000
Annuals > 3 > income Statement > eps
-45.81665793609219
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
238625
Annuals > 3 > income Statement > income Tax Expense
11000
Annuals > 3 > income Statement > EBITDA
-9450000
Annuals > 3 > income Statement > operating Margin
-2334.521158129176
Annuals > 3 > income Statement > total Other Income Expense Net
13879750
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2137000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2740000
Annuals > 3 > balance Sheet > property Plant Equipment
585000
Annuals > 3 > balance Sheet > total Assets
3391000
Annuals > 3 > balance Sheet > payables
624000
Annuals > 3 > balance Sheet > short Term Debt
5138000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
26002000
Annuals > 3 > balance Sheet > equity
-22611000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-10933000
Annuals > 3 > cash Flow > depreciation
153000
Annuals > 3 > cash Flow > change In Working Capital
1097000
Annuals > 3 > cash Flow > cash From Operations
-7774000
Annuals > 3 > cash Flow > capital Expenditures
206000
Annuals > 3 > cash Flow > cash From Investing
-215000
Annuals > 3 > cash Flow > cash From Financing
9810000
Annuals > 3 > cash Flow > net Change In Cash
1817000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-45.81665793609219
Annuals > 3 > ratios > PB
-0.012347585246119145
Annuals > 3 > ratios > ROE
48.35257175710937
Annuals > 3 > ratios > ROA
-322.41226776762016
Annuals > 3 > ratios > FCF
-7980000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-17.7728285077951
Annuals > 3 > health Score
31
Valuation > metrics > PE
3.25
Valuation > metrics > PB
0.8298915871639201
Valuation > final Score
90
Valuation > verdict
42.3% Undervalued
Profitability > metrics > ROE
-74.42902572997976
Profitability > metrics > ROA
-46.69024301777294
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9874241110147441
Risk > metrics > Interest Coverage
-123.1219512195122
Risk > final Score
-444
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.225504533489324
Liquidity > metrics > Quick Ratio
3.225504533489324
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-430
Prev Risks > 1
-251
Prev Risks > 2
-86
Prev Liquidities > 0
94
Prev Liquidities > 1
100
Prev Liquidities > 2
89
Updated At
2026-01-20T21:36:37.040Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.21
Earnings History > 0 > eps Estimate
-0.21
Earnings History > 0 > eps Difference
-2
Earnings History > 0 > surprise Percent
-952.381
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-08
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.99
Earnings History > 1 > eps Estimate
-0.21
Earnings History > 1 > eps Difference
-1.78
Earnings History > 1 > surprise Percent
-847.619
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
-0.25
Earnings History > 2 > eps Difference
0.07
Earnings History > 2 > surprise Percent
28
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.27
Earnings History > 3 > eps Estimate
-0.09
Earnings History > 3 > eps Difference
-0.18
Earnings History > 3 > surprise Percent
-200
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.65
Earnings History > 4 > eps Estimate
-0.19
Earnings History > 4 > eps Difference
-0.46
Earnings History > 4 > surprise Percent
-242.1053
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.4
Earnings History > 5 > eps Estimate
-0.19
Earnings History > 5 > eps Difference
-1.21
Earnings History > 5 > surprise Percent
-636.8421
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2
Earnings History > 6 > eps Estimate
-0.28
Earnings History > 6 > eps Difference
0.08
Earnings History > 6 > surprise Percent
28.5714
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-15
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.48
Earnings History > 7 > eps Estimate
-0.2
Earnings History > 7 > eps Difference
-0.28
Earnings History > 7 > surprise Percent
-140
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.14
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
17.6471
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.4321
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-27.0241
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.26
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.26
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.02
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-10
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.14
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.14
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.05
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.15
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.15
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.03
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABuy Signal: Should I average down on Popular Inc. stock - Portfolio Update Report & Safe Capital Growth Trade Ideas baoquankhu1.vn
Read more →Buybacks Report: How does JFBR perform in inflationary periods - Earnings Beat & AI Forecasted Stock Moves baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$120.0048
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Calidi Biotherapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.21
EPS Estimate
-0.21
EPS Difference
-2
Surprise Percent
-952.381%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.